- Home
- MYO vs DYAI Comparison
MYO vs DYAI Comparison
Compare MYO & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYO
- DYAI
- Stock Information
- Founded
- MYO 2004
- DYAI 1979
- Country
- MYO United States
- DYAI United States
- Employees
- MYO 185
- DYAI N/A
- Industry
- MYO Industrial Specialties
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MYO Health Care
- DYAI Health Care
- Exchange
- MYO Nasdaq
- DYAI Nasdaq
- Market Cap
- MYO 33.2M
- DYAI 30.2M
- IPO Year
- MYO 2017
- DYAI 2004
- Fundamental
- Price
- MYO $0.88
- DYAI $0.96
- Analyst Decision
- MYO Strong Buy
- DYAI Strong Buy
- Analyst Count
- MYO 3
- DYAI 1
- Target Price
- MYO $7.67
- DYAI $3.00
- AVG Volume (30 Days)
- MYO 833.3K
- DYAI 141.0K
- Earning Date
- MYO 11-10-2025
- DYAI 11-12-2025
- Dividend Yield
- MYO N/A
- DYAI N/A
- EPS Growth
- MYO N/A
- DYAI N/A
- EPS
- MYO N/A
- DYAI N/A
- Revenue
- MYO $41,643,203.00
- DYAI $3,342,195.00
- Revenue This Year
- MYO $24.69
- DYAI $18.18
- Revenue Next Year
- MYO $20.91
- DYAI $87.65
- P/E Ratio
- MYO N/A
- DYAI N/A
- Revenue Growth
- MYO 65.00
- DYAI N/A
- 52 Week Low
- MYO $0.71
- DYAI $0.71
- 52 Week High
- MYO $7.17
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- MYO 50.70
- DYAI 43.62
- Support Level
- MYO $0.71
- DYAI $0.90
- Resistance Level
- MYO $0.88
- DYAI $1.00
- Average True Range (ATR)
- MYO 0.07
- DYAI 0.09
- MACD
- MYO 0.01
- DYAI 0.00
- Stochastic Oscillator
- MYO 64.16
- DYAI 47.50
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.